These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15686942

  • 1. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
    Xin Z, Zhao H, Serby MD, Liu B, Schaefer VG, Falls DH, Kaszubska W, Colins CA, Sham HL, Liu G.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1201-4. PubMed ID: 15686942
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H, Xin Z, Patel JR, Nelson LT, Liu B, Szczepankiewicz BG, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL, Liu G.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1825-8. PubMed ID: 15780615
    [Abstract] [Full Text] [Related]

  • 3. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B, Liu G, Xin Z, Serby MD, Zhao H, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL.
    Bioorg Med Chem Lett; 2004 Oct 18; 14(20):5223-6. PubMed ID: 15380232
    [Abstract] [Full Text] [Related]

  • 4. Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.
    Zhao H, Xin Z, Liu G, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL.
    J Med Chem; 2004 Dec 30; 47(27):6655-7. PubMed ID: 15615511
    [Abstract] [Full Text] [Related]

  • 5. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
    Xin Z, Serby MD, Zhao H, Kosogof C, Szczepankiewicz BG, Liu M, Liu B, Hutchins CW, Sarris KA, Hoff ED, Falls HD, Lin CW, Ogiela CA, Collins CA, Brune ME, Bush EN, Droz BA, Fey TA, Knourek-Segel VE, Shapiro R, Jacobson PB, Beno DW, Turner TM, Sham HL, Liu G.
    J Med Chem; 2006 Jul 27; 49(15):4459-69. PubMed ID: 16854051
    [Abstract] [Full Text] [Related]

  • 6. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD, Zhao H, Szczepankiewicz BG, Kosogof C, Xin Z, Liu B, Liu M, Nelson LT, Kaszubska W, Falls HD, Schaefer V, Bush EN, Shapiro R, Droz BA, Knourek-Segel VE, Fey TA, Brune ME, Beno DW, Turner TM, Collins CA, Jacobson PB, Sham HL, Liu G.
    J Med Chem; 2006 Apr 20; 49(8):2568-78. PubMed ID: 16610800
    [Abstract] [Full Text] [Related]

  • 7. Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.
    Liu B, Liu M, Xin Z, Zhao H, Serby MD, Kosogof C, Nelson LT, Szczepankiewicz BG, Kaszubska W, Schaefer VG, Falls HD, Lin CW, Collins CA, Sham HL, Liu G.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1864-8. PubMed ID: 16442284
    [Abstract] [Full Text] [Related]

  • 8. Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor.
    Witherington J, Abberley L, Bellenie BR, Boatman R, Collis K, Dean DK, Gaiba A, King NP, Shuker N, Steadman JG, Takle AK, Sanger G, Butler S, McKay F, Muir A, Winborn K, Ward RW, Heightman TD.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):684-7. PubMed ID: 19128969
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
    Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Bergé G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.
    J Med Chem; 2007 Apr 19; 50(8):1939-57. PubMed ID: 17375904
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
    Budzik BW, Evans KA, Wisnoski DD, Jin J, Rivero RA, Szewczyk GR, Jayawickreme C, Moncol DL, Yu H.
    Bioorg Med Chem Lett; 2010 Feb 15; 20(4):1363-7. PubMed ID: 20097073
    [Abstract] [Full Text] [Related]

  • 11. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J, An M, Sapienza A, Aiyar N, Naselsky D, Sarau HM, Foley JJ, Salyers KL, Knight SD, Keenan RM, Rivero RA, Dhanak D, Douglas SA.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3950-4. PubMed ID: 18573659
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS, Benbow JW, Bonin PD, Boyer D, Doran SD, Frisbie RK, Piotrowski DW, Balan G, Bechle BM, Conn EL, Dirico KJ, Oliver RM, Soeller WC, Southers JA, Yang X.
    Bioorg Med Chem Lett; 2009 May 01; 19(9):2400-3. PubMed ID: 19346127
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
    Kobayashi T, Sasaki S, Tomita N, Fukui S, Kuroda N, Nakayama M, Kiba A, Takatsu Y, Ohtaki T, Itoh F, Baba A.
    Bioorg Med Chem; 2010 Jun 01; 18(11):3841-59. PubMed ID: 20457527
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
    Palin R, Abernethy L, Ansari N, Cameron K, Clarkson T, Dempster M, Dunn D, Easson AM, Edwards D, Maclean J, Everett K, Feilden H, Ho KK, Kultgen S, Littlewood P, McArthur D, McGregor D, McLuskey H, Neagu I, Neale S, Nisbet LA, Ohlmeyer M, Pham Q, Ratcliffe P, Rong Y, Roughton A, Sammons M, Swanson R, Tracey H, Walker G.
    Bioorg Med Chem Lett; 2011 Feb 01; 21(3):892-8. PubMed ID: 21236666
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships of the oxindole growth hormone secretagogues.
    Tokunaga T, Hume WE, Nagamine J, Kawamura T, Taiji M, Nagata R.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1789-92. PubMed ID: 15780607
    [Abstract] [Full Text] [Related]

  • 16. Proline bis-amides as potent dual orexin receptor antagonists.
    Bergman JM, Roecker AJ, Mercer SP, Bednar RA, Reiss DR, Ransom RW, Meacham Harrell C, Pettibone DJ, Lemaire W, Murphy KL, Li C, Prueksaritanont T, Winrow CJ, Renger JJ, Koblan KS, Hartman GD, Coleman PJ.
    Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1425-30. PubMed ID: 18207395
    [Abstract] [Full Text] [Related]

  • 17. Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
    Bonnefous C, Vernier JM, Hutchinson JH, Chung J, Reyes-Manalo G, Kamenecka T.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1197-200. PubMed ID: 15686941
    [Abstract] [Full Text] [Related]

  • 18. Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
    Ralbovsky JL, Lisko JG, Palmer JM, Mabus J, Chevalier KM, Schulz MJ, Dyatkin AB, Miskowski TA, Coats SJ, Hornby P, He W.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2661-3. PubMed ID: 19375913
    [Abstract] [Full Text] [Related]

  • 19. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
    Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1758-62. PubMed ID: 20137933
    [Abstract] [Full Text] [Related]

  • 20. Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.
    Ratcliffe P, Abernethy L, Ansari N, Cameron K, Clarkson T, Dempster M, Dunn D, Easson AM, Edwards D, Everett K, Feilden H, Ho KK, Kultgen S, Littlewood P, Maclean J, McArthur D, McGregor D, McLuskey H, Neagu I, Nimz O, Nisbet LA, Ohlmeyer M, Palin R, Pham Q, Rong Y, Roughton A, Sammons M, Swanson R, Tracey H, Walker G.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4652-7. PubMed ID: 21723725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.